K. Yoshimoto et al., TUMOR-SPECIFIC MUTATIONS IN THE TYROSINE KINASE DOMAIN OF THE RET PROTOONCOGENE IN PHEOCHROMOCYTOMAS OF SPORADIC TYPE, Endocrine journal, 42(2), 1995, pp. 265-270
Sporadic pheochromocytomas, sporadic medullary thyroid carcinomas (MTC
s), pheochromocytomas and/or MTCs in multiple endocrine neoplasia (MEN
) 2A or 2B were screened for mutations in the tyrosine kinase domain o
f the RET proto-oncogene by direct sequencing of PCR-amplified product
s or sequencing subcloned DNAs from PCR-products. All tumors of 4 MEN
2B patients were confirmed to contain a heterozygous missense mutation
at codon 918 (ATG-->ACG; Met-->Thr) of the RET proto-oncogene as well
as their leukocytes. The same tumor-specific mutations at codon 918 w
ere also found in 5/16 (31%) sporadic pheochromocytomas. These results
suggest that mutations of the RET proto-oncogene in its tyrosine kina
se domain play a role not only as the predisposing gene for MEN 2B, bu
t also as a tumorigenic factor for pheochromocytomas of sporadic type.